Ovary and Uterine Cancer (Tieman) Flashcards
most common genital tract malignancy in the US
carcinoma of the uterus
Most common clinical presentation is abnormal vaginal bleeding in perimenopausal or postmenopausal woman
risk factors for carcinoma of uterus
Obesity Unopposed estrogen stimulation (esp. postmenopausal) Tamoxifen Nulliparity Diabetes Late menopause Polycystic ovary syndrome Lynch syndrome
what decreases risk for getting carcinoma of uterus
Ovulation Progestin therapy Combination BCP’s Early menopause Multiparity
what 4 tests can you do first for evaluation of abnormal vaginal bleeding
Pelvic exam/Pap smear
Endometrial samping
Transvaginal ultrasound
Fractional D&C
how is a uterine carcinoma staged
surgery
Stage 1 uterine carcinoma
1a
1 b
1c
confined to uterine corpus
1a—confined to endometrium
1b—invasion to < ½ of myometrium
1c—invasion to > ½ of myometrium
stage 2 uterine carcinoma
invaded endocervix or cervix
stage 3 uterine
tumor in peritoneum, vagina or lymph nodes
stage 4 uterine
distant mets, invasion of bladder or bowel mucosa, inguinal lymph node involvement
what affects the prognosis of a carcinoma
grade and histology
grade 1 5 year survival (endometrum)
95%
grade 2 5 year survival endometrial
85%
grade 3 endometrial carcinoma 5 yr survival
70%
what type of endometrial carcinomas have favorable histology? what type have unfavorable ?
80% are favorable histology (Endometroid) 20% are unfavorable Papillary serous carcinoma Clear-cell carcinoma Squamous cell carcinoma Poorly differentiated carcinoma
Stage 1a and 1b,Grades I and II, favorable histology can be treated with what
TAH-BSO, peritoneal washings and removal of any enlarged lymph nodes
Grade 3 or unfavorable histology, stage 1c or stage 2 tumors require what treatment
TAH-BSO, cytology, and iliac/para-aortic node dissection +/- radiation
stage 3 and 4 endometrial cancer treatment
Stages 3 & 4 require surgical debulking + radiation + chemotherapy
stage 1 a endometiral and 1 b 5 year survival
90%
stage 1 c uterine 5 year survival
80%
stage 2 uterine surival 5 years
70-80%
stage 3 endometrial 5 year survival
30-60%
stage 4 endometrial 5 year
15%
second most common but number 1 most lethal cancer of female genital tract
ovarian cancer
increased risk for ovarian cancer>?
White race/USA Nulliparity/infertility Late childbearing Late menopause Family history BRCA genetic mutation